Select Page
SmartCatch was founded to provide oncology research and treatment centers with a powerful tool that can be used in clinical routine to capture CTCs for early diagnosis, personalization of the therapeutic project and longitudinal follow-up Cancer of pathologies.

Device for capturing circulating tumor cells

In Vivo Physical Capture

Patented technology

Precision medicine is the adaptation of a medical treatment to the specific characteristics of each patient that can be determined by the analysis of a number of biomarkers. In this perspective, and unlike current tools based on in vitro analyzes, the innovation lies in the in vivo use of a 3D micro-object allowing a capture based on the physical characteristics of the CTCs. Manufactured using cutting-edge microfabrication technologies, this device was developed using advanced fluidic simulation software and validated on fluidic benches.

Innovative technology

"Label Free" Physical Capture

Limits selection bias
U

In Vivo

Limits sampling bias

Reproducible

Allowing longitudinal follow-up of the patient

Our team

Dr Cerf

Dr Cerf

Researcher - LAAS / CNRS

Dr Sanson

Dr Sanson

Urologist - CHU Rangueil

Mr Francois Malavaud

CEO

Pr Malavaud

Pr Malavaud

Urologist – IUCT

Dr Oudjedi

Dr Oudjedi

CTO

Pr Vieu

Pr Vieu

Researcher - LAAS / CNRS

Contact us

More information

Founded in September 2016, SmartCatch is a research start-up jointly led by an academic team specialized in micro/nanotechnologies from the Laboratoire d’Analyse et d’Architecture des Systèmes (LAAS-CNRS) and urology surgeons and oncologists of the University Institute of Cancer (IUCT) and the CHU of Rangueil.

Address:

1 Av. Irène Joliot-Curie – 31100 Toulouse